Fiasp ultra-fast acting insulin

Evaluation of the effect of Fiasp ultra-fast acting insulin

The IRCM clinic is seeking volunteers for a research project on the comparison of ultra-fast acting insulin (FIASP) and fast acting insulin (Novorapid) on blood sugar management during exercise following a meal. 

Financial compensation will be given. The project is being carried out under the supervision of Dr. Rémi Rabasa-Lhoret.


  • Clinical diagnosis of type 1 diabetes for at least 1 year
  • Be over 18 years of age
  • Using multiple daily injections as a treatment modality (basal/bolus)


This study involves a total of five visits (Montreal), including one admission visit and four intervention visits. The admission visit lasts about two hours and will determine your eligibility to participate in the study. 

Intervention visits last about five hours. Breakfast will be served in the morning and two different strategies will be tested: one-hour cycling one hour after the meal, and two hours after the meal.